GNC has been the subject of several other research reports. Gabelli reissued a hold rating on shares of GNC in a research note on Tuesday, March 5th. Zacks Investment Research raised GNC from a sell rating to a hold rating in a research note on Wednesday, January 23rd. Three analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the company’s stock. GNC has a consensus rating of Hold and an average price target of $4.13.
Shares of GNC stock opened at $1.63 on Friday. The stock has a market capitalization of $136.03 million, a PE ratio of 4.79 and a beta of 0.84. GNC has a 1-year low of $1.59 and a 1-year high of $4.65.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. FMR LLC grew its stake in GNC by 0.4% during the first quarter. FMR LLC now owns 7,912,006 shares of the specialty retailer’s stock worth $21,600,000 after purchasing an additional 35,000 shares during the period. Oxford Asset Management LLP acquired a new stake in GNC during the first quarter worth approximately $375,000. Geode Capital Management LLC grew its stake in GNC by 7.1% during the first quarter. Geode Capital Management LLC now owns 920,719 shares of the specialty retailer’s stock worth $2,513,000 after purchasing an additional 61,059 shares during the period. Charles Schwab Investment Management Inc. grew its stake in GNC by 348.3% during the first quarter. Charles Schwab Investment Management Inc. now owns 5,396,953 shares of the specialty retailer’s stock worth $14,734,000 after purchasing an additional 4,193,020 shares during the period. Finally, Renaissance Technologies LLC grew its stake in GNC by 191.5% during the first quarter. Renaissance Technologies LLC now owns 653,999 shares of the specialty retailer’s stock worth $1,785,000 after purchasing an additional 429,666 shares during the period. 46.77% of the stock is owned by institutional investors and hedge funds.
GNC Holdings, Inc, together with its subsidiaries, operates as a specialty retailer of health, wellness, and performance products. The company operates through three segments: U.S. and Canada, International, and Manufacturing/Wholesale. Its products include proteins, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty products, food and drink products, and other general merchandise.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for GNC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC and related companies with MarketBeat.com's FREE daily email newsletter.